Select region
Menu
  • Products and Solutionsmore
    • Intensive Care
    • Cardiovascular Procedures
    • Operating Room
    • Sterile Reprocessing
    • Digital Health
    • Pharmaceutical Production
    • Research Laboratories

    • View all products →
  • Servicesmore
    • Technical Services
    • Digital Services
    • Financial Services
    • Planning and Design
    • Project Implementation
    • Education and Training
    • Hospital Transformational Partnerships

    • View all Services →
  • Insightsmore
    • Academy
    • Articles
    • Events (tapahtumat)
    • Getinge Experience Center
    • Idea and invention submission

    • Insights main page →
  • Companymore
    • Corporate Governance
    • Sustainability
    • Business Ethics
    • News
    • Careers
    • Investors
    • Grants and Charitable Donations
    • History

    • Company main page →
    • News
    • Legal Information
    • Instructions For Use/Patient Information
    • Product Catalog
    • COVID-19 Resource Center
    • Investors
    • Careers
  • Ota yhteyttä
  • Suomi (Suomalainen)
    • Global
      • International (English)
    • EMEA
      • Sverige (Svenska)
      • Deutschland (Deutsch)
      • France (Français)
      • United Kingdom / Ireland (English)
      • Italia (Italiano)
      • Türkiye (Türkçe)
      • Polska (polski)
      • Россия (русский)
      • Spain (Español)
      • Denmark (Dansk)
      • Norge (Norsk)
      • Suomi (Suomalainen)
      • Benelux (Nederlands)
    • Americas
      • United States (English)
      • Brazil (Português)
      • Canada (English)
      • Canada (Français)
      • Latin America (Español)
    • Asia
      • 日本 (日本語)
      • 中国 (中文)
      • 한국어(대한민국)
      • South East Asia (English)
      • India (English)
    • Oceania
      • Australia / New Zealand (English)
  • Products and Solutions
    • Intensive Care
    • Cardiovascular Procedures
    • Operating Room
    • Sterile Reprocessing
    • Digital Health
    • Pharmaceutical Production
    • Research Laboratories

    • View all products →
  • Services
    • Technical Services
    • Digital Services
    • Financial Services
    • Planning and Design
    • Project Implementation
    • Education and Training
    • Hospital Transformational Partnerships

    • View all Services →
  • Insights
    • Academy
    • Articles
    • Events (tapahtumat)
    • Getinge Experience Center
    • Idea and invention submission

    • Insights main page →
  • Company
    • Corporate Governance
    • Sustainability
    • Business Ethics
    • News
    • Careers
    • Investors
    • Grants and Charitable Donations
    • History

    • Company main page →
  • Ota yhteyttä
  • Aloita
  • Company
  • Corporate Governance
  • General meetings

General meetings

The General Meeting of Shareholders is Getinge’s highest decision-making body through which the Shareholders exercise their influence over the company. The Annual General Meeting is held annually within six months of the end of the financial year and Shareholders can at the Annual General Meeting exercise their voting rights on various key matters. The Board can also convene and Extraordinary General Meeting.

  • Overview
  • Article of association
  • General meetings
  • Policies
  • Board of directors
  • Nomination committee
  • External auditor
  • Remuneration
  • Executive team
  • Corporate governance and auditor's reports
  • Board committees

Participation

Shareholders who wish to participate in and vote for their shares at the General Meeting must be registered in the share register and notify their participation.* Shareholders who are unable to attend in person may be represented by a proxy.

Location

Getinge's Annual General Meeting is held in Gothenburg or Halmstad no later than six months after the end of the financial year. The time and venue for the meeting are announced, at the latest, in connection with the interim report for the third quarter.

Notice to Attend

The notice to attend the General Meeting is published 4-6 weeks before the meeting in Post- och Inrikes Tidningar and on the company's website. An announcement that the notice to attend has been published is made in Svenska Dagbladet.

* The notice of participation to attend the General Meeting specifies how to give notice to the company and provides other information about participation in the General Meeting. The notice must be received within a certain time prior to the general meeting.

Matters at the Annual General Meeting

The Shareholders are informed about the development of the company during the past year. Key matters addressed at the Annual General Meeting are, for example, decisions made regarding the company and group's income statements and balance sheets, allocation of the company's profit, discharge from liability for the Board members and CEO, election of and remuneration for the Board members and the auditors, and any other issues in accordance with law or the articles of association.

Matters by request of Shareholders

A Shareholder is entitled to have a matter addressed at the General Meeting, provided that the board has received such request no later than one week before the notice to attend may be published at the earliest. The matter will be addressed also if the request is received later than said time, if the matter can be included in the notice to attend. A Shareholder who wishes to have a matter considered by the General Meeting must submit a written proposal to the meeting.

Extraordinary Shareholders Meeting

An Extraordinary General Meeting may be convened at the discretion of the Board of Directors, or if the auditors or a Shareholder who own no less then 10% of the shares request such meeting to be held. Matters to be handled on such meeting should be specified in writing in the request.

Annual General Meeting 2025

Read more

Annual General Meeting 2024

Read more

Annual General Meeting 2023

Read more

Annual General Meeting 2022

Read more

Annual General Meeting 2021

Read more

Annual General Meeting 2020

Read more

Annual General Meeting 2019

Read more

Annual General Meeting 2018

Read more

Extraordinary General Meeting December 2017

Read more

Extraordinary General Meeting August 2017

Read more

Annual General Meeting 2017

Read more

Annual General Meeting 2016

Read more

Annual General Meeting 2015

Read more

Annual General Meeting 2014

Read more

Annual General Meeting 2013

Read more

Annual General Meeting 2012

Read more

Annual General Meeting 2011

Read more

Annual General Meeting 2010

Read more

Annual General Meeting 2009

Read more

Olet nyt poistumassa Getinge.com-sivustolta. Saatat päästä käsiksi sisältöön, jota Getinge-tiimi ei hallinnoi, jolloin Getinge ei ole vastuussa sisällöstä. 

Ymmärrän!

Our offer

  • Products and Solutions
  • Services

Support and tools

  • Insights
  • Events
  • Past Webinars
  • Instructions For Use/Patient Information
  • Security

Company

  • Investors
  • Careers
  • Corporate Governance
  • History
  • Legal Information
  • Website Privacy Policy
  • Website use disclaimer
  • Data Subject Request Form
Ota yhteyttä
Suomi (Suomalainen)
  • Global
    • International (English)
  • EMEA
    • Sverige (Svenska)
    • Deutschland (Deutsch)
    • France (Français)
    • United Kingdom / Ireland (English)
    • Italia (Italiano)
    • Türkiye (Türkçe)
    • Polska (polski)
    • Россия (русский)
    • Spain (Español)
    • Denmark (Dansk)
    • Norge (Norsk)
    • Suomi (Suomalainen)
    • Benelux (Nederlands)
  • Americas
    • United States (English)
    • Brazil (Português)
    • Canada (English)
    • Canada (Français)
    • Latin America (Español)
  • Asia
    • 日本 (日本語)
    • 中国 (中文)
    • 한국어(대한민국)
    • South East Asia (English)
    • India (English)
  • Oceania
    • Australia / New Zealand (English)
Suomi (Suomalainen)

© 2025 Getinge │ Getinge ja

Getinge_Logo_hz_RGB_neg.png

ovat Getinge AB:n, sen tytäryhtiöiden tai osakkuusyhtiöiden tavaramerkkejä tai rekisteröityjä tavaramerkkejä.

marraskuu 2024

Nämä tiedot on tarkoitettu vain terveydenhuollon ammattilaisille tai muille alan ammattilaisille, ja ne on tarkoitettu vain tiedoksi. Ne eivät ole kattavia, eikä niitä siksi tule pitää käyttöohjeen, huolto-oppaan tai lääketieteellisen neuvonnan korvikkeena. Getinge ei ole vastuussa mistään sellaisista toimista tai laiminlyönneistä, jotka perustuvat tähän aineistoon, ja siihen luottaminen tapahtuu yksinomaan käyttäjän omalla vastuulla.

Mainittu hoito, ratkaisu tai tuote ei välttämättä ole saatavilla maassasi tai sen käyttö ei ole siellä sallittua. Tietoja ei saa kopioida tai käyttää kokonaan tai osittain ilman Getingen kirjallista lupaa.

Nämä tiedot on tarkoitettu kansainväliselle yleisölle Yhdysvaltojen ulkopuolella.

Ilmaistut näkemykset, mielipiteet ja väitteet ovat haastatellun omia eivätkä välttämättä heijasta tai edusta Getingen näkemyksiä.